Chemoinformaics analysis of Stigmast-7-en-3-one
| Molecular Weight | 412.702 | nRot | 6 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 21 |
| Exact Molecular Weight | 412.371 | nRing | 4 |
| Solubility: LogS | -6.93 | nHRing | 0 |
| Solubility: LogP | 7.467 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 81.2381 |
| nHD | 0 | BPOL | 49.0219 |
| QED | 0.401 |
| Synth | 4.536 |
| Natural Product Likeliness | 2.681 |
| NR-PPAR-gamma | 0.094 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.276 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.767 |
| MDCK | 0.00000587 |
| BBB | 0.978 |
| PPB | 0.990421 |
| VDSS | 1.449 |
| FU | 0.0109313 |
| CYP1A2-inh | 0.047 |
| CYP1A2-sub | 0.523 |
| CYP2c19-inh | 0.097 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.298 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.69 |
| CYP3a4-inh | 0.294 |
| CYP3a4-sub | 0.65 |
| CL | 17.138 |
| T12 | 0.016 |
| hERG | 0.014 |
| Ames | 0.01 |
| ROA | 0.039 |
| SkinSen | 0.022 |
| Carcinogencity | 0.036 |
| EI | 0.014 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.678113 |